Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Collier

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Clinical Rheumatology|October 6, 2016
The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritisAtul Deodhar, Bojena Bitman, Yue Yang, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 7, 2006
Anticardiolipin antibodies in sclerodermaRaymond J Enzenauer, David H Collier, Luis R Lopez
Arthritis & Rheumatology (Hoboken, N.J.)|April 9, 2020
ReplyPhilip J Mease, David H Collier, Gregory Kricorian, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 11, 2010
A concise evaluation and management curriculum for physicians in training improved billing at an outpatient academic rheumatology clinicJoel M Hirsh, David H Collier, Dennis J Boyle, et al.
Postgraduate Medicine|November 11, 2016
A novel electromechanical autoinjector, AutoTouch™, for self-injection of etanercept: real-world use and benefitsDavid H Collier, Bojena Bitman, Andrew Coles, et al.
The Journal of Rheumatology|March 17, 2010
Health literacy predicts the discrepancy between patient and provider global assessments of rheumatoid arthritis activity at a public urban rheumatology clinicJoel M Hirsh, Dennis J Boyle, David H Collier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 12, 2015
Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic DrugsNeil A Accortt, Machaon M Bonafede, David H Collier, et al.
Springerplus|March 21, 2015
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapyKathryn Hobbs, Atul Deodhar, Brian Wang, et al.
Arthritis Care & Research|June 23, 2015
Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid ArthritisMachaon Bonafede, Barbara H Johnson, Derek H Tang, et al.
Arthritis Care & Research|March 14, 2020
Potential for Major Therapeutic Changes to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans With Rheumatoid ArthritisBrian C Sauer, Wei Chen, Jincheng Shen, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Clinical Rheumatology|October 6, 2016
The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritisAtul Deodhar, Bojena Bitman, Yue Yang, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 7, 2006
Anticardiolipin antibodies in sclerodermaRaymond J Enzenauer, David H Collier, Luis R Lopez
Arthritis & Rheumatology (Hoboken, N.J.)|April 9, 2020
ReplyPhilip J Mease, David H Collier, Gregory Kricorian, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 11, 2010
A concise evaluation and management curriculum for physicians in training improved billing at an outpatient academic rheumatology clinicJoel M Hirsh, David H Collier, Dennis J Boyle, et al.
Postgraduate Medicine|November 11, 2016
A novel electromechanical autoinjector, AutoTouch™, for self-injection of etanercept: real-world use and benefitsDavid H Collier, Bojena Bitman, Andrew Coles, et al.
The Journal of Rheumatology|March 17, 2010
Health literacy predicts the discrepancy between patient and provider global assessments of rheumatoid arthritis activity at a public urban rheumatology clinicJoel M Hirsh, Dennis J Boyle, David H Collier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 12, 2015
Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic DrugsNeil A Accortt, Machaon M Bonafede, David H Collier, et al.
Springerplus|March 21, 2015
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapyKathryn Hobbs, Atul Deodhar, Brian Wang, et al.
Arthritis Care & Research|June 23, 2015
Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid ArthritisMachaon Bonafede, Barbara H Johnson, Derek H Tang, et al.
Arthritis Care & Research|March 14, 2020
Potential for Major Therapeutic Changes to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans With Rheumatoid ArthritisBrian C Sauer, Wei Chen, Jincheng Shen, et al.
Pageof 5